The UK government has introduced regulations to halt new private prescriptions of puberty blockers for under-18s before the general election, affecting patients with gender dysphoria.
NHS England decided that puberty blockers would only be available to young people as part of clinical trials, stating they should not be routinely commissioned outside of research settings.
Collection
[
|
...
]